Arcutis Biotherapeutics I... (ARQT)
NASDAQ: ARQT
· Real-Time Price · USD
16.91
0.93 (5.82%)
At close: Aug 15, 2025, 3:59 PM
16.61
-1.75%
After-hours: Aug 15, 2025, 07:30 PM EDT
Arcutis Biotherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 81.5M | 65.85M | 71.36M | 44.76M | 30.86M | 49.57M | 13.53M | 38.11M | 5.19M | 2.78M | 2.96M | 725K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 7.49M | 8.83M | 6.91M | 5.5M | 3.46M | 3.26M | 2.25M | 1.18M | 776K | 783K | 485K | 269K | 234K | 229K | 211K | 192K | 182K | 178K |
Gross Profit | 74.01M | 57.02M | 64.45M | 39.25M | 27.39M | 46.31M | 11.28M | 36.93M | 4.41M | 2M | 2.48M | 456K | -234K | -229K | -211K | -192K | -182K | -178K |
Operating Income | -14.61M | -24.53M | -7.63M | -39.07M | -50.08M | -31.62M | -61.17M | -36.9M | -66.76M | -76.27M | -68.42M | -104.75M | -65.83M | -62.63M | -71.29M | -57.08M | -42.08M | -36.09M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -15.54M | -24.78M | -10.46M | -41.54M | -52.33M | -35.06M | -66.26M | -41.74M | -70.99M | -80.1M | -72.02M | -107.71M | -67.41M | -64.32M | -71.33M | -56.98M | -42.01M | -36.04M |
Net Income | -15.89M | -25.06M | -10.79M | -41.54M | -52.33M | -35.38M | -66.28M | -44.77M | -70.99M | -79.74M | -75.61M | -107.71M | -68.98M | -66.02M | -71.33M | -56.98M | -42.01M | -36.04M |
Selling & General & Admin | 69.17M | 64M | 57.61M | 58.82M | 58.17M | 54.79M | 48.48M | 47.59M | 45.96M | 42.92M | 37.02M | 35.47M | 27.62M | 22.01M | 18.73M | 16.47M | 11.31M | 14.45M |
Research & Development | 19.45M | 17.54M | 14.48M | 19.5M | 19.3M | 23.14M | 23.77M | 26.24M | 25.22M | 35.34M | 33.88M | 69.73M | 38.2M | 40.62M | 52.56M | 40.6M | 30.77M | 21.63M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 421K | 142K | -40K | 98K | 72K | 43K |
Operating Expenses | 88.62M | 81.55M | 72.09M | 78.32M | 77.47M | 77.94M | 72.25M | 73.83M | 71.18M | 78.26M | 70.9M | 105.2M | 65.83M | 62.63M | 71.29M | 57.08M | 42.08M | 36.09M |
Interest Expense | 3.03M | 2.98M | 5.55M | 6.65M | 7.48M | 7.48M | 7.76M | 7.56M | 7.35M | 7.04M | 6.92M | 4.9M | 2M | 1.84M | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -88M | n/a | n/a | 37.13M | -12.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 96.11M | 90.38M | 78.99M | 83.82M | 80.94M | 81.19M | 74.69M | 75.01M | 71.95M | 79.05M | 71.39M | 105.47M | 65.83M | 62.63M | 71.29M | 57.08M | 42.08M | 36.09M |
Income Tax Expense | 342K | 279K | 323K | n/a | n/a | 324K | 25K | 3.02M | n/a | -363K | 3.6M | n/a | 1.58M | 1.7M | -136K | -76K | -78K | -98K |
Shares Outstanding (Basic) | 127M | 126.04M | 120.96M | 124.3M | 123.48M | 111.05M | 92.58M | 61.73M | 61.43M | 61.17M | 60.96M | 57.09M | 51.42M | 50.51M | 50.2M | 50.1M | 50M | 47.28M |
Shares Outstanding (Diluted) | 127M | 126.04M | 120.96M | 124.3M | 123.48M | 111.05M | 92.58M | 61.73M | 61.43M | 61.17M | 60.96M | 57.09M | 51.42M | 50.51M | 50.2M | 50.1M | 50M | 47.28M |
EPS (Basic) | -0.13 | -0.2 | -0.09 | -0.33 | -0.42 | -0.32 | -0.72 | -0.73 | -1.16 | -1.3 | -1.24 | -1.94 | -1.34 | -1.31 | -1.42 | -1.14 | -0.84 | -0.76 |
EPS (Diluted) | -0.13 | -0.2 | -0.09 | -0.33 | -0.42 | -0.32 | -0.72 | -0.73 | -1.16 | -1.3 | -1.24 | -1.94 | -1.34 | -1.31 | -1.42 | -1.14 | -0.84 | -0.76 |
EBITDA | -11.95M | -18.67M | -4.46M | -33.45M | -44.5M | -27.22M | -58.11M | -33.8M | -63.26M | -72.69M | -64.76M | -102.57M | -65.25M | -62.34M | -71.11M | -56.79M | -41.9M | -35.94M |
EBIT | -12.52M | -21.8M | -4.91M | -34.88M | -44.85M | -27.58M | -58.5M | -34.18M | -63.64M | -73.06M | -65.1M | -102.81M | -65.41M | -62.49M | -71.29M | -56.98M | -42.01M | -36.04M |
Depreciation & Amortization | 563K | 3.13M | 458K | 1.43M | 351K | 358K | 385K | 387K | 474K | 363K | 429K | 236K | 234K | 229K | 211K | 192K | 104K | 98K |